Description
A histamine H1 receptor antagonist (Ki = 4.4 nM) that also blocks ERG potassium channels (IC50 = ~1 nM); used to study long QT syndrome type 2 and as an antineoplastic agent for decreasing proliferation of various cancer cells
Formal name: 1-[(4-fluorophenyl)methyl]-N-[1-[2-(4-methoxyphenyl)ethyl]-4-piperidinyl]-1H-benzimidazol-2-amine
Synonyms: NSC 329963
Molecular weight: 458.6
CAS: 68844-77-9
Purity: ≥98%
Formulation: A crystalline solid
Application|Mass Spectrometry||Product Type|Biochemicals|Ion Channel Modulation|Blockers||Product Type|Biochemicals|Receptor Pharmacology|Antagonists||Research Area|Cancer||Research Area|Cardiovascular System|Heart|Arrhythmia||Research Area|Immunology & Inflammation|Allergy